These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 32726410

  • 21. Shared and Tissue-Specific Expression Signatures between Bone Marrow from Primary Myelofibrosis and Essential Thrombocythemia.
    Ishikawa G, Fujiwara N, Hirschfield H, Varricchio L, Hoshida Y, Barosi G, Rosti V, Padilla M, Mazzarini M, Friedman SL, Hoffman R, Migliaccio AR.
    Exp Hematol; 2019 Nov; 79():16-25.e3. PubMed ID: 31678370
    [Abstract] [Full Text] [Related]

  • 22. Targeting megakaryocytic-induced fibrosis in myeloproliferative neoplasms by AURKA inhibition.
    Wen QJ, Yang Q, Goldenson B, Malinge S, Lasho T, Schneider RK, Breyfogle LJ, Schultz R, Gilles L, Koppikar P, Abdel-Wahab O, Pardanani A, Stein B, Gurbuxani S, Mullally A, Levine RL, Tefferi A, Crispino JD.
    Nat Med; 2015 Dec; 21(12):1473-80. PubMed ID: 26569382
    [Abstract] [Full Text] [Related]

  • 23. Identification of oncostatin M as a JAK2 V617F-dependent amplifier of cytokine production and bone marrow remodeling in myeloproliferative neoplasms.
    Hoermann G, Cerny-Reiterer S, Herrmann H, Blatt K, Bilban M, Gisslinger H, Gisslinger B, Müllauer L, Kralovics R, Mannhalter C, Valent P, Mayerhofer M.
    FASEB J; 2012 Feb; 26(2):894-906. PubMed ID: 22051730
    [Abstract] [Full Text] [Related]

  • 24. Remodeling the Bone Marrow Microenvironment - A Proposal for Targeting Pro-inflammatory Contributors in MPN.
    Jutzi JS, Mullally A.
    Front Immunol; 2020 Feb; 11():2093. PubMed ID: 32983162
    [Abstract] [Full Text] [Related]

  • 25. X-linked thrombocytopenia with thalassemia displays bone marrow reticulin fibrosis and enhanced angiogenesis: comparisons with primary myelofibrosis.
    Åström M, Hahn-Strömberg V, Zetterberg E, Vedin I, Merup M, Palmblad J.
    Am J Hematol; 2015 Mar; 90(3):E44-8. PubMed ID: 25421114
    [Abstract] [Full Text] [Related]

  • 26. Mesenchymal stem cells in myeloproliferative disorders - focus on primary myelofibrosis.
    Selicean SE, Tomuleasa C, Grewal R, Almeida-Porada G, Berindan-Neagoe I.
    Leuk Lymphoma; 2019 Apr; 60(4):876-885. PubMed ID: 30277128
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A proinflammatory stem cell niche drives myelofibrosis through a targetable galectin-1 axis.
    Li R, Colombo M, Wang G, Rodriguez-Romera A, Benlabiod C, Jooss NJ, O'Sullivan J, Brierley CK, Clark SA, Pérez Sáez JM, Fernández PA, Schoof EM, Porse B, Meng Y, Khan AO, Wen S, Dong P, Zhou W, Sousos N, Murphy L, Clarke M, Olijnik AA, Wong ZC, Karali CS, Sirinukunwattana K, Ryou H, Norfo R, Cheng Q, Carrelha J, Ren Z, Thongjuea S, Rathinam VA, Krishnan A, Royston D, Rabinovich GA, Mead AJ, Psaila B.
    Sci Transl Med; 2024 Oct 09; 16(768):eadj7552. PubMed ID: 39383242
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Focus on Osteosclerotic Progression in Primary Myelofibrosis.
    Spampinato M, Giallongo C, Romano A, Longhitano L, La Spina E, Avola R, Scandura G, Dulcamare I, Bramanti V, Di Rosa M, Vicario N, Parenti R, Li Volti G, Tibullo D, Palumbo GA.
    Biomolecules; 2021 Jan 19; 11(1):. PubMed ID: 33477816
    [Abstract] [Full Text] [Related]

  • 31. β-catenin and PPAR-γ levels in bone marrow of myeloproliferative neoplasm: an immunohistochemical and ultrastructural study.
    Subotički T, Mitrović Ajtić O, Mićić M, Kravić Stevović T, Đikić D, Diklić M, Leković D, Gotić M, Čokić VP.
    Ultrastruct Pathol; 2018 Jan 19; 42(6):498-507. PubMed ID: 30582392
    [Abstract] [Full Text] [Related]

  • 32. Bone marrow-specific loss of ABI1 induces myeloproliferative neoplasm with features resembling human myelofibrosis.
    Chorzalska A, Morgan J, Ahsan N, Treaba DO, Olszewski AJ, Petersen M, Kingston N, Cheng Y, Lombardo K, Schorl C, Yu X, Zini R, Pacilli A, Tepper A, Coburn J, Hryniewicz-Jankowska A, Zhao TC, Oancea E, Reagan JL, Liang O, Kotula L, Quesenberry PJ, Gruppuso PA, Manfredini R, Vannucchi AM, Dubielecka PM.
    Blood; 2018 Nov 08; 132(19):2053-2066. PubMed ID: 30213875
    [Abstract] [Full Text] [Related]

  • 33. JAK2(V617F) allele burden discriminates essential thrombocythemia from a subset of prefibrotic-stage primary myelofibrosis.
    Hussein K, Bock O, Theophile K, von Neuhoff N, Buhr T, Schlué J, Büsche G, Kreipe H.
    Exp Hematol; 2009 Oct 08; 37(10):1186-1193.e7. PubMed ID: 19616600
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Association of mast cells and bone marrow reticulin fibrosis in patients with bcr-abl negative chronic myeloproliferative neoplasms.
    Keski H.
    Blood Cells Mol Dis; 2020 May 08; 82():102420. PubMed ID: 32179412
    [Abstract] [Full Text] [Related]

  • 36. The effects of hematopoietic stem cell transplant on splenic extramedullary hematopoiesis in patients with myeloproliferative neoplasm-associated myelofibrosis.
    Pizzi M, Gergis U, Chaviano F, Orazi A.
    Hematol Oncol Stem Cell Ther; 2016 Sep 08; 9(3):96-104. PubMed ID: 27521149
    [Abstract] [Full Text] [Related]

  • 37. Adhesion to fibronectin via α5β1 integrin supports expansion of the megakaryocyte lineage in primary myelofibrosis.
    Matsuura S, Thompson CR, Ng SK, Ward CM, Karagianni A, Mazzeo C, Malara A, Balduini A, Ravid K.
    Blood; 2020 Jun 18; 135(25):2286-2291. PubMed ID: 32294178
    [Abstract] [Full Text] [Related]

  • 38. Mutations associated with age-related clonal hematopoiesis in PMF patients with rapid progression to myelofibrosis.
    Bartels S, Faisal M, Büsche G, Schlue J, Hasemeier B, Schipper E, Vogtmann J, Westphal L, Lehmann U, Kreipe H.
    Leukemia; 2020 May 18; 34(5):1364-1372. PubMed ID: 31776465
    [Abstract] [Full Text] [Related]

  • 39. Macrophage frequency in the bone marrow correlates with morphologic subtype of myeloproliferative neoplasm.
    Molitor DCA, Boor P, Buness A, Schneider RK, Teichmann LL, Körber RM, Horvath GL, Koschmieder S, Gütgemann I.
    Ann Hematol; 2021 Jan 18; 100(1):97-104. PubMed ID: 33104881
    [Abstract] [Full Text] [Related]

  • 40. Primary myelofibrosis is the most frequent myeloproliferative neoplasm associated with del(5q): clinicopathologic comparison of del(5q)-positive and -negative cases.
    Santana-Davila R, Tefferi A, Holtan SG, Ketterling RP, Dewald GW, Knudson RA, Steensma DP, Chen D, Hoyer JD, Hanson CA.
    Leuk Res; 2008 Dec 18; 32(12):1927-30. PubMed ID: 18538839
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.